Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Sato, M. Ohta, Y. Kawaguchi, H. Okada, M. Ono, H. Saito, M. Utsunomiya, T. Tamura, K. Sugimoto, S. Takamizawa (1995)
Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism.Mineral and electrolyte metabolism, 21 1-3
K. Boström, K. Watson, S. Horn, C. Wortham, I. Herman, L. Demer (1993)
Bone morphogenetic protein expression in human atherosclerotic lesions.The Journal of clinical investigation, 91 4
P. Kööbi, T. Vehmas, P. Jolma, J. Kalliovalkama, M. Fan, O. Niemelä, H. Saha, M. Kähönen, P. Ylitalo, J. Rysä, H. Ruskoaho, I. Pörsti (2006)
High-calcium vs high-phosphate intake and small artery tone in advanced experimental renal insufficiency.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 21 10
M. Avram, N. Mittman, M. Myint, P. Fein (2001)
Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation.American journal of kidney diseases : the official journal of the National Kidney Foundation, 38 6
Wei Xiang, J. Kong, Songcang Chen, Li-ping Cao, Guilin Qiao, Wei Zheng, Wenhua Liu, Xinmin Li, D. Gardner, Y. Li (2005)
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems.American journal of physiology. Endocrinology and metabolism, 288 1
A. Levey, K. Eckardt, Y. Tsukamoto, A. Levin, J. Coresh, J. Rossert, D. Zeeuw, T. Hostetter, N. Lameire, G. Eknoyan (2005)
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney international, 67 6
T. O’Connell, J. Berry, Amy Jarvis, M. Somerman, R. Simpson (1997)
1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy.The American journal of physiology, 272 4 Pt 2
G. Chertow, S. Burke, P. Raggi (2002)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.Kidney international, 62 1
F. Koiwa, T. Kakuta, Reika Tanaka, S. Yumita (2006)
Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22 2
M. Wada, H. Ishii, Y. Furuya, J. Fox, E. Nemeth, N. Nagano (1998)
NPS R-568 halts or reverses osteitis fibrosa in uremic rats.Kidney international, 53 2
Dumitru Branisteanu, P. Leenaerts, B. Damme, R. Bouillon (1993)
Partial prevention of active Heymann nephritis by lα, 25 dihydroxyvitamin D3Clinical & Experimental Immunology, 94
N. Nagano, S. Miyata, S. Obana, N. Kobayashi, N. Fukushima, S. Burke, M. Wada (2003)
Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 10
S. Massry, J. Coburn, G. Chertow, K. Hruska, C. Langman, H. Malluche, K. Martin, L. Mccann, J. McCarthy, S. Moe, I. Salusky, Donald Sherrand, M. Smogorzewski, K. Bolton, C. Turkelson, K. Tappe, S. Tregear, J. Reston, W. Bruening, Mark Monteforte, Janice Kaczmarek, V. Coates, G. Bailie, B. Becker, G. Becker, J. Burrowes, F. Carrera, D. Churchill, A. Collins, P. Crooks, D. Dezeeuw, T. Golper, F. Gotch, A. Gotto, R. Greenwood, J. Greer, R. Grimm, W. Haley, R. Hogg, A. Hull, L. Hunsicker, C. Johnson, M. Klag, S. Klahr, N. Lameire, F. Locatelli, S. McCulloch, Maureen Michael, J. Nally, J. Newmann, A. Nissenson, Keith Norris, G. Obrador, W. Owen, T. Patel, G. Payne, C. Ronco, R. Rivera-Mizzoni, A. Schoolwerth, R. Star, M. Steffes, T. Steinman, J. Wauters, N. Wenger, J. Briggs, T. Hostetter, G. Eknoyan, A. Levin, N. Levin, S. Andreoli, S. Burrows‐Hudson, D. Latos, D. Mapes, E. Oberley, B. Pereira, Nadine Ferguson, D. Fingerhut, A. Gucciardo, M. Klette, D. Mallard, K. Willis (2003)
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.American journal of kidney diseases : the official journal of the National Kidney Foundation, 42 4 Suppl 3
D. McCarron, C. Morris (1985)
Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial.Annals of internal medicine, 103 6 ( Pt 1)
G. Isaia, M. Stefano, Simona Bergui (2006)
The pleiotropic actions of vitamin D
M. Sandgren, M. Brönnegärd, H. DeLuca (1991)
Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat.Biochemical and biophysical research communications, 181 2
A. Hutchison, B. Maes, J. Vanwalleghem, G. Asmus, E. Mohamed, R. Schmieder, W. Backs, R. Jamar, A. Vosskühler (2005)
Long-Term Effi cacy and Tolerability of Lanthanum Carbonate : Results from a 3-Year Study
A. Duggal, M. Hanus, E. Zhorov, R. Dagher, M. Plone, J. Goldberg, S. Burke (2006)
Novel dosage forms and regimens for sevelamer-based phosphate binders.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 16 3
M. Cozzolino, M. Staniforth, H. Liapis, J. Finch, S. Burke, A. Dusso, E. Slatopolsky (2003)
Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.Kidney international, 64 5
P. Price, J. Buckley, M. Williamson (2001)
The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats.The Journal of nutrition, 131 11
M. Teng, M. Wolf, E. Lowrie, N. Ofsthun, J. Lazarus, R. Thadhani (2003)
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.The New England journal of medicine, 349 5
J. Lindberg, S. Moe, W. Goodman, J. Coburn, S. Sprague, Wei Liu, P. Blaisdell, R. Brenner, S. Turner, K. Martin (2003)
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.Kidney international, 63 1
S. Jono, M. McKee, C. Murry, A. Shioi, Y. Nishizawà, K. Mori, H. Morii, C. Giachelli (2000)
Phosphate regulation of vascular smooth muscle cell calcification.Circulation research, 87 7
W. Kriz, K. Lemley (1999)
The role of the podocyte in glomerulosclerosis.Current opinion in nephrology and hypertension, 8 4
Y. Lien, Arnold Silva, D. Whittman (2005)
Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 20 6
S. Moe, T. Drüeke, J. Cunningham, Wayne Goodman, K. Martin, K. O̸lgaard, S. Ott, S. Sprague, N. Lameire, G. Eknoyan (2006)
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney international, 69 11
H. Orita, T. Akizawa (2004)
[Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].Clinical calcium, 14 5
(2002)
Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcifi cation in hemodialysis patients
M. Fukagawa, J. Kazama, T. Shigematsu (2002)
Management of patients with advanced secondary hyperparathyroidism: the Japanese approach.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 9
Jianming Wu, M. Garami, T. Cheng, D. Gardner (1996)
1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes.The Journal of clinical investigation, 97 7
E. Brown, M. Pollak, S. Hebert (1998)
The extracellular calcium-sensing receptor: its role in health and disease.Annual review of medicine, 49
K. Katsumata, K. Kusano, M. Hirata, K. Tsunemi, N. Nagano, S. Burke, N. Fukushima (2003)
Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.Kidney international, 64 2
(1999)
The role of the podocyte in glomerulosclero
Kerstin Amann, Golo Kronenberg, Frank Gehlen, Sabine Wessels, Stephan Orth, Klaus Münter, Heimo Ehmke, G. Mall, Eberhard Ritz (1998)
Cardiac remodelling in experimental renal failure--an immunohistochemical study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 13 8
F. Parhami, B. Basseri, J. Hwang, Y. Tintut, L. Demer (2002)
High-Density Lipoprotein Regulates Calcification of Vascular CellsCirculation Research: Journal of The American Heart Association, 91
S. Moe, G. Chertow, J. Coburn, L. Quarles, W. Goodman, G. Block, Tilman DrEke, J. Cunningham, D. Sherrard, L. McCary, K. Olson, S. Turner, K. Martin (2005)
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.Kidney international, 67 2
S. Ganesh, A. Stack, N. Levin, T. Hulbert-Shearon, F. Port (2001)
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.Journal of the American Society of Nephrology : JASN, 12 10
R. Weishaar, S. Kim, D. Saunders, R. Simpson (1990)
Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties.The American journal of physiology, 258 1 Pt 1
H. Ishii, M. Wada, Y. Furuya, N. Nagano, E. Nemeth, J. Fox (2000)
Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.Bone, 26 2
M. Fukagawa, T. Akizawa (2005)
Calcium abnormalities of dialysis patientsJournal of Bone and Mineral Metabolism, 24
(2006)
Guidelines for the management of secondary hyperparathyroidism in chronic dialysis patientsJ Jpn Soc Dial Ther, 39
K. Amann, J. Törnig, B. Kugel, M. Gross, K. Tyralla, A. El-Shakmak, A. Szabó, E. Ritz (2003)
Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.Kidney international, 63 4
SM Moe, GM Chertow, JW Coburn, LD Quarles, WG Goodman, GA Block (2005)
Achieving NKF-K/DOQI bone metabolism and disease goals with cinacalcet HClKidney Int, 67
M. Haussler, G. Whitfield, C. Haussler, J. Hsieh, P. Thompson, S. Selznick, C. Dominguez, P. Jurutka (1998)
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 13
J. Shao, Su‐Li Cheng, J. Pingsterhaus, N. Charlton-Kachigian, A. Loewy, D. Towler (2005)
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals.The Journal of clinical investigation, 115 5
K. Shiizaki, S. Negi, I. Hatamura, T. Sakaguchi, F. Saji, K. Kunimoto, Masahide Mizobuchi, I. Imazeki, A. Ooshima, T. Akizawa (2004)
Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.Journal of the American Society of Nephrology : JASN, 16 1
Michaela Pfeifer, B. Begerow, Helmut Minne, D. Nachtigall, C. Hansen (2001)
Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.The Journal of clinical endocrinology and metabolism, 86 4
T. Odenwald, K. Nakagawa, Charlotte Hadtstein, F. Roesch, P. Gohlke, E. Ritz, F. Schaefer, C. Schmitt (2006)
Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats.Journal of the American Society of Nephrology : JASN, 17 3
B. Lacour, A. Lucas, D. Auchère, Nadya Ruellan, Natalie Patey, T. Drüeke (2005)
Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration.Kidney international, 67 3
J. Silberberg, P. Barré, S. Prichard, A. Sniderman (1989)
Impact of left ventricular hypertrophy on survival in end-stage renal disease.Kidney international, 36 2
Magdalena Pajda, Anna Matug, M. Widlak, K. Antoniak, R. Ficek, J. Chudek, A. Więcek (2006)
Influence of parathyroidectomy on blood pressure and function of the transplanted kidney in patients with tertiary hyperparathyroidism.Annals of transplantation, 11 1
E. Slatopolsky, Alex Brown, A. Dusso (1999)
Pathogenesis of secondary hyperparathyroidism.Kidney international. Supplement, 73
F. Tentori, W. Hunt, C. Stidley, M. Rohrscheib, E. Bedrick, K. Meyer, H. Johnson, P. Zager (2006)
Mortality risk among hemodialysis patients receiving different vitamin D analogs.Kidney international, 70 10
U. Schwarz, Kerstin Amann, S. Orth, Aureliza Simonaviciene, Sabine Wessels, Eberhard Ritz (1998)
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats.Kidney international, 53 6
G. Block, T. Hulbert-Shearon, Nathan Levin, F. Port (1998)
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.American journal of kidney diseases : the official journal of the National Kidney Foundation, 31 4
P. Parfrey, R. Foley, J. Harnett, G. Kent, D. Murray, P. Barré (1996)
Outcome and risk factors for left ventricular disorders in chronic uraemia.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 11 7
K. Neves, F. Graciolli, L. Reis, C. Pasqualucci, R. Moysés, V. Jorgetti (2004)
Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.Kidney international, 66 6
槙林 弘之郎 (2002)
A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis
P. Ducy, Rui Zhang, V. Geoffroy, A. Ridall, G. Karsenty (1997)
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast DifferentiationCell, 89
T. Shoji, K. Shinohara, Eiji Kimoto, M. Emoto, H. Tahara, H. Koyama, M. Inaba, S. Fukumoto, E. Ishimura, T. Miki, T. Tabata, Y. Nishizawà (2004)
Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 19 1
M. Hirata, K. Makibayashi, K. Katsumata, K. Kusano, Takeshi Watanabe, N. Fukushima, T. Doi (2002)
22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 12
M. Melamed, J. Eustace, L. Plantinga, B. Jaar, N. Fink, J. Coresh, M. Klag, N. Powe (2006)
Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.Kidney international, 70 2
J. Cunningham (2006)
Management of secondary hyperparathyroidism.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 9 Suppl 1
JS Silberberg, PE Barre, SS Prichard, AD Sniderman (1989)
Impact of LVH on survival in end-stage renal diseaseKidney Int, 36
T. Akizawa, Y. Ohashi, T. Akiba, Masashi Suzuki, Y. Nishizawà, E. Ogata, E. Slatopolsky, K. Kurokawa (2004)
Dose‐response Study of 22‐Oxacalcitriol in Patients with Secondary HyperparathyroidismTherapeutic Apheresis and Dialysis, 8
M. Avram, R. Sreedhara, D. Avram, R. Muchnick, P. Fein (1996)
Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia.American journal of kidney diseases : the official journal of the National Kidney Foundation, 28 6
A. Stack, R. Saran (2002)
Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States.American journal of kidney diseases : the official journal of the National Kidney Foundation, 40 6
P. Jolma, P. Kööbi, J. Kalliovalkama, H. Saha, M. Fan, J. Jokihaara, E. Moilanen, I. Tikkanen, I. Pörsti (2003)
Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 12
G. Block, K. Martin, A. Francisco, S. Turner, M. Avram, M. Suranyi, G. Hercz, J. Cunningham, A. Abu-Alfa, P. Messa, D. Coyne, F. Locatelli, R. Cohen, P. Evenepoel, S. Moe, A. Fournier, J. Braun, L. McCary, V. Zani, K. Olson, T. Drüeke, W. Goodman (2004)
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.The New England journal of medicine, 350 15
M. Marco, L. Craver, À. Betriu, M. Belart, J. Fibla, E. Fernández (2003)
Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population.Kidney international. Supplement, 85
Y. Li, J. Kong, Minjie Wei, Zhoudao Chen, Shu Liu, Li-ping Cao (2002)
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJournal of Clinical Investigation, 110
N. Nagano (2006)
Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism.Pharmacology & therapeutics, 109 3
A. Kuhlmann, C. Haas, M. Gross, U. Reulbach, M. Holzinger, U. Schwarz, E. Ritz, K. Amann (2004)
1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.American journal of physiology. Renal physiology, 286 3
Alex Brown, A. Dusso, E. Slatopolsky (2002)
Vitamin D analogues for secondary hyperparathyroidism.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 Suppl 10
(2001)
Effects of PB-94 (sevelamer hydrochloride), a phosphate binder, on the treatment of hyperphosphatemia in hemodialysis. A randomized, open label, dose-titration study of PB-94 versus Caltan (abstract)
Hiroaki Ogata, Eberhard Ritz, G. Odoni, Kerstin Amann, Stephan Orth (2003)
Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors.Journal of the American Society of Nephrology : JASN, 14 4
J. Reynolds, A. Joannides, J. Skepper, R. McNair, L. Schurgers, D. Proudfoot, W. Jahnen-Dechent, P. Weissberg, C. Shanahan (2004)
Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.Journal of the American Society of Nephrology : JASN, 15 11
E. Young, Justin Albert, S. Satayathum, D. Goodkin, R. Pisoni, T. Akiba, T. Akizawa, K. Kurokawa, J. Bommer, L. Piera, F. Port (2005)
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.Kidney international, 67 3
J. Cunningham, M. Danese, K. Olson, P. Klassen, G. Chertow (2005)
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.Kidney international, 68 4
K. Amann, J. Törnig, C. Flechtenmacher, A. Nabokov, G. Mall, E. Ritz (1995)
Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 10 11
H. Tahara, Y. Tsujimoto, T. Shoji, M. Inaba, T. Tabata, Y. Nishizawà (2005)
Introduction to Sevelamer Hydrochloride and its Clinical EffectsTherapeutic Apheresis and Dialysis, 9
L. Quarles, D. Sherrard, S. Adler, S. Rosansky, L. McCary, Wei Liu, S. Turner, D. Bushinsky (2003)
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.Journal of the American Society of Nephrology : JASN, 14 3
Cheol Park, Yong Oh, Young Shin, Chul-Min Kim, Yong-Soo Kim, Suk Kim, Eui-Jin Choi, Y. Chang, Byung Bang (1999)
Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism.American journal of kidney diseases : the official journal of the National Kidney Foundation, 33 1
C. Charytan, J. Coburn, M. Chonchol, J. Herman, Y. Lien, Wei Liu, P. Klassen, L. McCary, V. Pichette (2005)
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.American journal of kidney diseases : the official journal of the National Kidney Foundation, 46 1
R. Foley, P. Parfrey, M. Sarnak (1998)
Epidemiology of cardiovascular disease in chronic renal disease.Journal of the American Society of Nephrology : JASN, 9 12 Suppl
M. Cozzolino, A. Dusso, H. Liapis, J. Finch, Yan Lu, S. Burke, E. Slatopolsky (2002)
The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.Journal of the American Society of Nephrology : JASN, 13 9
V. Panichi, M. Migliori, D. Taccola, C. Filippi, Laura Nisco, Luca Giovannini, Roberto Palla, Ciro Tetta, Giovanni Camussi (2001)
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.Kidney international, 60 1
A. Hutchison, B. Maes, J. Vanwalleghem, G. Asmus, E. Mohamed, R. Schmieder, W. Backs, R. Jamar, A. Vosskühler (2005)
Long-Term Efficacy and Tolerability of Lanthanum Carbonate: Results from a 3-Year StudyNephron Clinical Practice, 102
H. Ogata, F. Koiwa, Hidetoshi Ito, E. Kinugasa (2006)
Therapeutic Strategies for Secondary Hyperparathyroidism in Dialysis PatientsTherapeutic Apheresis and Dialysis, 10
A. Hutchison, M. Speake, Fouad Al-Baaj (2004)
Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 19 7
I. Lopez, E. Aguilera-Tejero, F. Mendoza, Y. Almadén, J. Pérez, David Martin, Mariano Rodríguez (2006)
Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.Journal of the American Society of Nephrology : JASN, 17 3
Steven Achinger, J. Ayus (2005)
The role of vitamin D in left ventricular hypertrophy and cardiac function.Kidney international. Supplement, 95
Masahide Mizobuchi, I. Hatamura, H. Ogata, F. Saji, S. Uda, K. Shiizaki, T. Sakaguchi, S. Negi, E. Kinugasa, S. Koshikawa, T. Akizawa (2004)
Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.Journal of the American Society of Nephrology : JASN, 15 10
N. Santo, A. Frangiosa, P. Anastasio, A. Marino, G. Correale, A. Perna, E. Stazio, D. Stellato, D. Santoro, E. Meglio, G. Iacono, C. Ciacci, V. Savica, M. Cirillo (2006)
Sevelamer worsens metabolic acidosis in hemodialysis patients.Journal of nephrology, 19 Suppl 9
G. Block, P. Klassen, J. Lazarus, N. Ofsthun, E. Lowrie, G. Chertow (2004)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.Journal of the American Society of Nephrology : JASN, 15 8
Chronic kidney disease (CKD) causes various bone mineral disorders, which have recently been named CKD mineral and bone disorder (CKD-MBD). CKD-MBD is associated with extremely high cardiovascular disease (CVD) morbidity and mortality in the endstage kidney disease (ESKD) population. Thus, optimal management of CKD-MBD would lead to a reduction in cardiovascular morbidity and mortality in uremic patients. In addition, it has been suggested that the treatment of CKD-MBD has some favorable effects on the progression of CKD. Recently, novel therapeutic agents, including active vitamin D analogues, noncalcium-containing phosphate binders, and cinacalcet, have become clinically available. In this article, we review novel therapeutic strategies for CKD-MBD.
Clinical and Experimental Nephrology – Springer Journals
Published: Dec 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.